Increased osteoclastic activity in acute Charcot's osteoarthropathy: the role of receptor activator of nuclear factor-kappaB ligand.
about
Interleukin-32 promotes osteoclast differentiation but not osteoclast activationRole of the A20-TRAF6 axis in lipopolysaccharide-mediated osteoclastogenesisThe Charcot foot in diabetesProinflammatory modulation of the surface and cytokine phenotype of monocytes in patients with acute Charcot footThe RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic Charcot neuroarthropathyInhibition of TNF-α Reverses the Pathological Resorption Pit Profile of Osteoclasts from Patients with Acute Charcot Osteoarthropathy.Role of Wnt/β-catenin and RANKL/OPG in bone healing of diabetic Charcot arthropathy patients.Cutaneous structural and biochemical correlates of foot complications in high-risk diabetes.Augmented LPS responsiveness in type 1 diabetes-derived osteoclasts.Risk factors of diabetic foot Charcot arthropathy: a case-control study at a Malaysian tertiary care centre.An overview of the Charcot foot pathophysiology.Hyperglycemia induced and intrinsic alterations in type 2 diabetes-derived osteoclast functionAssociation between osteoprotegerin G1181C and T245G polymorphisms and diabetic charcot neuroarthropathy: a case-control study.Inflammation as a Therapeutic Target for Diabetic Neuropathies.Treatment of acute Charcot foot with bisphosphonates: a systematic review of the literature.The pathogenesis of Charcot neuroarthropathy: current concepts.Medical management of Charcot arthropathy.Etiology, pathophysiology and classifications of the diabetic Charcot footNeuropathy and the vascular-bone axis in diabetes: lessons from Charcot osteoarthropathy.RANKL-OPG and RAGE modulation in vascular calcification and diabetes: novel targets for therapy.Surgical management of Charcot neuroarthropathy.Charcot foot syndrome.Circulating monocytes: an appropriate model for bone-related study.The diabetic foot in 2015: an overview.Effects of Type 1 Diabetes on Osteoblasts, Osteocytes, and Osteoclasts.Charcot stage 0: A review and consideratons for making the correct diagnosis early.Loss of RAGE defense: a cause of Charcot neuroarthropathy?Acute Charcot neuro-osteoarthropathy.Pathogenesis and potential relative risk factors of diabetic neuropathic osteoarthropathy.Number of circulating CD14-positive cells and the serum levels of TNF-α are raised in acute charcot foot.Diabetic osteoarthropathy care in Sweden - Need for improvement: A national inventoryNovel use of a Dektak 150 surface profiler unmasks differences in resorption pit profiles between control and Charcot patient osteoclasts.Osteoprotegerin gene polymorphism in diabetic Charcot neuroarthropathy.Autoantibodies to post-translationally modified type I and II collagen in Charcot neuroarthropathy in subjects with type 2 diabetes mellitus.Corneal confocal microscopy detects severe small fibre neuropathy in diabetes patients with charcot neuroarthropathy.Neuroarthropathy in diabetes: pathogenesis of Charcot arthropathy.Markers of Local Inflammation and Bone Resorption in the Acute Diabetic Charcot Foot
P2860
Q21092154-3879D7B6-BA97-4FAD-AA57-31586485DDD2Q24311417-550A371E-06FF-4ED4-82CE-AE65AF290EA0Q24612582-423FD9E7-FE69-4CDE-8D9D-ED6ABA68DEC6Q33602274-E1E6025A-EB8E-4695-B00A-C8F3ABC45C02Q35123561-F958DEC0-15B7-4C8F-BB62-E6D6E8DFB1EBQ35744929-D665BBC4-0228-4AC1-B8F5-2631E82A77DEQ35885233-FFAC1F43-C023-4DF2-B195-B8442138401EQ36181308-5CC5A680-F64E-42A3-938D-CD6BCE0BD446Q36315765-939DBD68-7F3D-4710-9924-A72CFE4BE739Q36859321-CA934F19-36DD-405D-8E74-5444A00E56DEQ37068742-F73FBB3B-23C7-4FB2-81AD-66C31E266983Q37238209-2DDC8380-C3AB-4DD9-AABA-BFA24DD8A48BQ37319080-7630FB9B-3B98-4682-B574-8A5C8D434316Q37450547-4FB8DEFB-0BA0-4E38-90B7-D9AFE1AC6CE4Q37987820-9FB7C137-991B-4D29-8590-6AADCA3E5B72Q37991311-DE27EBA7-E229-472A-BFCE-FFB146196658Q38031994-BF018DCA-9CBD-4189-8384-E40FC3E4AC1AQ38109166-FF1352F0-5DDB-4FA2-B5C6-DCD594192143Q38148953-1BF726A5-DA83-486A-A197-B7EAA1DA3C45Q38238914-F659F570-B14A-4A2A-BD1D-71E73A717B50Q38329638-9B643FAC-FC92-4712-B35A-EB49E92F9077Q38394379-17D4A9B7-775E-4983-847E-8958C871A0F3Q38551006-0A6FFE5B-843E-43EB-8A08-0991E475E892Q38602992-B99B6B2C-8F32-46E1-BBF6-E7B0E78DCDA6Q38972516-9B4448B8-698C-459D-BE20-8EE617CB1E08Q39431686-72175B19-5BCE-4F34-9C4A-D31186D2718FQ39748819-1757DEDA-CC49-452F-A58A-A8C559A19708Q41241823-E933E1CF-850C-46DF-8E18-DD34D9EBAF01Q42284515-477686BE-6A95-4D0E-8E76-A4A21FADA291Q42613527-B70DF79B-2075-41B3-A52F-0140F1FD4A7FQ42656566-F9F3F358-F62C-4BFD-B36E-B65A4AE2E9E6Q45253652-E4F31B95-0DE4-40FB-BB08-CFB42F295B4BQ45255263-A41CCC5B-814E-478D-90C0-7E08A8AEE384Q46511647-F94E3CA1-11E7-434A-956B-474F92015382Q49585762-15A2B509-862A-4322-93DC-01A7921129DAQ55280458-8E8629A2-D3B8-47F9-AF3F-D6E06F246175Q58803025-5786E89B-ECFB-48E9-A956-F246735FBE2E
P2860
Increased osteoclastic activity in acute Charcot's osteoarthropathy: the role of receptor activator of nuclear factor-kappaB ligand.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Increased osteoclastic activit ...... nuclear factor-kappaB ligand.
@ast
Increased osteoclastic activit ...... nuclear factor-kappaB ligand.
@en
type
label
Increased osteoclastic activit ...... nuclear factor-kappaB ligand.
@ast
Increased osteoclastic activit ...... nuclear factor-kappaB ligand.
@en
prefLabel
Increased osteoclastic activit ...... nuclear factor-kappaB ligand.
@ast
Increased osteoclastic activit ...... nuclear factor-kappaB ligand.
@en
P2093
P2860
P1433
P1476
Increased osteoclastic activit ...... nuclear factor-kappaB ligand.
@en
P2093
A Sabokbar
G Mabilleau
M E Edmonds
N L Petrova
P2860
P2888
P304
P356
10.1007/S00125-008-0992-1
P577
2008-04-04T00:00:00Z